Fludarabine and cyclophosphamide combination in the treatment of patients with indolent non-follicular B-cell non-Hodgkin's lymphomas. Results of a phase II trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).

Fludarabine and cyclophosphamide combination in the treatment of patients with indolent non-follicular B-cell non-Hodgkin's lymphomas. Results of a phase II trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL) / Federico, Massimo; Luminari, Stefano; Brugiatelli, M; Goldaniga, M; Sacchi, Stefano; Merli, F; Stelitano, C; Bagnulo, A; Rizzo, M; Baldini, L.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 23:16(2005), pp. 588S-588S.